Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States.
Discovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
J Med Chem. 2022 Jan 27;65(2):1525-1535. doi: 10.1021/acs.jmedchem.1c01186. Epub 2021 Oct 14.
The front pocket (FP) N-terminal cap (Ncap) cysteine is the most popular site of covalent modification in kinases. A long-standing hypothesis associates the Ncap position with cysteine hyper-reactivity; however, traditional computational predictions suggest that the FP Ncap cysteines are predominantly unreactive. Here we applied the state-of-the-art continuous constant pH molecular dynamics (CpHMD) to test the Ncap hypothesis. Simulations found that the Ncap cysteines of BTK/BMX/TEC/ITK/TXK, JAK3, and MKK7 are reactive to varying degrees; however, those of BLK and EGFR/ERBB2/ERBB4 possessing a Ncap+3 aspartate are unreactive. Analysis suggested that hydrogen bonding and electrostatic interactions drive the reactivity, and their absence renders the Ncap cysteine unreactive. To further test the Ncap hypothesis, we examined the FP Ncap+2 cysteines in JNK1/JNK2/JNK3 and CASK. Our work offers a systematic understanding of the cysteine structure-reactivity relationship and illustrates the use of CpHMD to differentiate cysteines toward the design of targeted covalent inhibitors with reduced chemical reactivities.
前口袋 (FP) N 端帽 (Ncap) 半胱氨酸是激酶中最常见的共价修饰位点。一个长期存在的假说将 Ncap 位置与半胱氨酸的高反应性联系起来;然而,传统的计算预测表明 FP Ncap 半胱氨酸主要是无反应的。在这里,我们应用最先进的连续恒 pH 分子动力学 (CpHMD) 来测试 Ncap 假说。模拟发现 BTK/BMX/TEC/ITK/TXK、JAK3 和 MKK7 的 Ncap 半胱氨酸具有不同程度的反应性;然而,那些具有 Ncap+3 天冬氨酸的 BLK 和 EGFR/ERBB2/ERBB4 则没有反应性。分析表明,氢键和静电相互作用驱动反应性,而它们的缺失使 Ncap 半胱氨酸无反应性。为了进一步验证 Ncap 假说,我们检查了 JNK1/JNK2/JNK3 和 CASK 中的 FP Ncap+2 半胱氨酸。我们的工作提供了对半胱氨酸结构-反应性关系的系统理解,并说明了如何使用 CpHMD 来区分半胱氨酸,从而设计具有降低化学反应性的靶向共价抑制剂。